Cargando…

Peptide Inhibitors of the Interaction of the SARS-CoV-2 Receptor-Binding Domain with the ACE2 Cell Receptor

Computer simulation has been used to identify peptides that mimic the natural target of the SARS-CoV-2 coronavirus spike (S) protein, the angiotensin-converting enzyme type 2 (ACE2) cell receptor. Based on the structure of the complex of the protein S receptor-binding domain (RBD) and ACE2, the desi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bibilashvili, R. Sh., Sidorova, M. V., Dudkina, U. S., Palkeeva, M. E., Molokoedov, A. S., Kozlovskaya, L. I., Egorov, A. M., Ishmukhametov, A. A., Parfyonova, E.V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Pleiades Publishing 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8562373/ https://www.ncbi.nlm.nih.gov/pubmed/34745440 http://dx.doi.org/10.1134/S199075082104003X

Ejemplares similares

Properties and Activity of Peptide Derivatives of ACE2 Cellular Receptor and Their Interaction with SARS-CoV-2 S Protein Receptor-Binding Domain
por: Sidorova, M. V., et al.
Publicado: (2022)

SARS-CoV-2 Binding and Neutralization Properties of Peptides Derived from N-Terminus of Human ACE2
por: Astrakhantseva, Irina V., et al.
Publicado: (2023)

Cardioprotective properties of N-terminal galanin fragment (2-15) in experimental ischemia/reperfusion injury
por: Pisarenko, Oleg, et al.
Publicado: (2017)

Effects of structural analogues of apelin-12 in acute myocardial infarction in rats
por: Pisarenko, Oleg I., et al.
Publicado: (2013)

Expanded ACE2 dependencies of diverse SARS-like coronavirus receptor binding domains
por: Roelle, Sarah M., et al.
Publicado: (2022)

Myocardial protection from ischemia/reperfusion injury by exogenous galanin fragment
por: Timotin, Andrei, et al.
Publicado: (2017)

ACE2: from vasopeptidase to SARS virus receptor
por: Turner, Anthony J, et al.
Publicado: (2004)

Atomistic insights into the binding of SARS-CoV-2 spike receptor binding domain with the human ACE2 receptor: The importance of residue 493
por: Carter, Camryn, et al.
Publicado: (2023)

Endocytosis of the receptor-binding domain of SARS-CoV spike protein together with virus receptor ACE2
por: Wang, Shunxin, et al.
Publicado: (2008)

Benzimidazole compound abrogates SARS-COV-2 receptor-binding domain (RBD)/ACE2 interaction In vitro
por: Omotuyi, Olaposi, et al.
Publicado: (2023)

Correlating the differences in the receptor binding domain of SARS-CoV-2 spike variants on their interactions with human ACE2 receptor
por: Mahalingam, Gokulnath, et al.
Publicado: (2023)

Genetic Landscape of the ACE2 Coronavirus Receptor
por: Yang, Zhijian, et al.
Publicado: (2022)

In-Silico Drug Designing of Spike Receptor with Its ACE2 Receptor and Nsp10/Nsp16 MTase Complex Against SARS-CoV-2
por: Siddiqa, M A., et al.
Publicado: (2021)

Lung Surfactant Protein B Peptide Mimics Interact with the Human ACE2 Receptor
por: Waring, Alan J., et al.
Publicado: (2023)

Antibodies to neutralising epitopes synergistically block the interaction of the receptor‐binding domain of SARS‐CoV‐2 to ACE 2
por: Pandey, Manisha, et al.
Publicado: (2021)

Virus-Receptor Interactions of Glycosylated SARS-CoV-2 Spike and Human ACE2 Receptor
por: Zhao, Peng, et al.
Publicado: (2020)

Virus-Receptor Interactions of Glycosylated SARS-CoV-2 Spike and Human ACE2 Receptor
por: Zhao, Peng, et al.
Publicado: (2020)

Small Molecules and Peptides Targeting Glial Cell Line-Derived Neurotrophic Factor Receptors for the Treatment of Neurodegeneration
por: Sidorova, Yulia A., et al.
Publicado: (2020)

Deep mutational scanning of SARS-CoV-2 receptor binding domain reveals constraints on folding and ACE2 binding
por: Starr, Tyler N., et al.
Publicado: (2020)

ACE2 Receptor and Its Isoform Short-ACE2 Are Expressed on Human Spermatozoa
por: Ramal-Sanchez, Marina, et al.
Publicado: (2022)

Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding
por: Starr, Tyler N., et al.
Publicado: (2020)

Angiotensin type-1 receptor and ACE2 autoantibodies in Parkinson´s disease
por: Labandeira, Carmen M., et al.
Publicado: (2022)

Engineered ACE2 receptor traps potently neutralize SARS-CoV-2
por: Glasgow, Anum, et al.
Publicado: (2020)

Engineered ACE2 receptor traps potently neutralize SARS-CoV-2
por: Glasgow, Anum, et al.
Publicado: (2020)

Development of a SARS-CoV-2-derived receptor-binding domain-based ACE2 biosensor
por: Suh, Jung-Soo, et al.
Publicado: (2021)

Promising terpenes as SARS-CoV-2 spike receptor-binding domain (RBD) attachment inhibitors to the human ACE2 receptor: Integrated computational approach
por: Muhseen, Ziyad Tariq, et al.
Publicado: (2020)

Competitive SARS-CoV-2 Serology Reveals Most Antibodies Targeting the Spike Receptor-Binding Domain Compete for ACE2 Binding
por: Byrnes, James R., et al.
Publicado: (2020)

Trimeric receptor-binding domain of SARS-CoV-2 acts as a potent inhibitor of ACE2 receptor-mediated viral entry
por: Basavarajappa, Shrikanth C., et al.
Publicado: (2022)

Human Angiotensin - Converting Enzyme 2 (ACE2) is a Receptor for Human Respiratory Coronavirus NL63
por: Smith, M. K., et al.
Publicado: (2006)

Heterogeneous expression of the SARS-Coronavirus-2 receptor ACE2 in the human respiratory tract
por: Ortiz, Miguel E., et al.
Publicado: (2020)

Heterogeneous expression of the SARS-Coronavirus-2 receptor ACE2 in the human respiratory tract
por: Ortiz Bezara, Miguel E., et al.
Publicado: (2020)

Angiotensin receptor-neprilysin inhibitors and cardiac remodeling
por: Ryazanov, A.S., et al.
Publicado: (2023)

Deep mutational learning predicts ACE2 binding and antibody escape to combinatorial mutations in the SARS-CoV-2 receptor-binding domain
por: Taft, Joseph M., et al.
Publicado: (2022)

Synthetic Peptides That Antagonize the Angiotensin-Converting Enzyme-2 (ACE-2) Interaction with SARS-CoV-2 Receptor Binding Spike Protein
por: Sadremomtaz, Afsaneh, et al.
Publicado: (2021)

Engineering ACE2 decoy receptors to combat viral escapability
por: Arimori, Takao, et al.
Publicado: (2022)

Possible host-adaptation of SARS-CoV-2 due to improved ACE2 receptor binding in mink
por: Welkers, Matthijs R A, et al.
Publicado: (2021)

ACE2 and ACE: structure-based insights into mechanism, regulation and receptor recognition by SARS-CoV
por: Lubbe, Lizelle, et al.
Publicado: (2020)

On the interactions of the receptor-binding domain of SARS-CoV-1 and SARS-CoV-2 spike proteins with monoclonal antibodies and the receptor ACE2
por: Corrêa Giron, Carolina, et al.
Publicado: (2020)

Effect of An 84-bp Deletion of the Receptor-Binding Domain on the ACE2 Binding Affinity of the SARS-CoV-2 Spike Protein: An In Silico Analysis
por: Kemenesi, Gábor, et al.
Publicado: (2021)

Development of a nano-luciferase based assay to measure the binding of SARS-CoV-2 spike receptor binding domain to ACE-2
por: Lima, Marcelo A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_alkkl367ulej6gk1fipppqotc0